Resource-limited countries have limited laboratory capability and rely on syndromic management to diagnose sexually transmitted infections (STIs). We aimed to estimate the sensitivity, specificity and positive predictive value (PPV) of STI syndromic management when used as a screening method within a study setting. Men who have sex with men (MSM), female sex workers (FSWs) and people living with HIV/AIDS (PLWHA) participated in a behavioural surveillance study. Data were obtained on demographics, sexual behaviours, STI history and service utilisation. Biological specimens were tested for genital inflammatory infections (Neisseria gonorrhoeae [GC], Chlamydia trachomatis [CT], Mycoplasma genitalium [MG], Trichomonas vaginalis [TV]) and genital ulcerative infection (syphilis and Herpes simplex virus-2). There was a high prevalence of Herpes simplex virus-2 (MSM 48.1%, FSW 82.0% and PLWHA 84.4%). Most participants reported no ulcerative symptoms and the majority of men reported no inflammatory symptoms. Sensitivity and PPV were poor for inflammatory infections among PLWHA and MSM. Sensitivity in FSWs for inflammatory infections was 75%. For ulcerative infections, sensitivity was poor, but specificity and PPV were high. Reliance on self-reported symptoms may not be an effective screening strategy for these populations. STI prevention studies should focus on symptom recognition and consider routine screening and referral for high-risk populations.
Introduction
Though controversy exists about the role of treating sexually transmitted infections (STIs) as part of HIV prevention programming, in resource-limited countries with a concentrated HIV epidemic and where STI services are limited but where STIs have a high prevalence, improved STI treatment can potentially reduce the incidence of HIV. [1] [2] [3] [4] [5] Additionally, STIs themselves are a public health concern and cause significant morbidity, mortality and economic costs. 6 In countries with a generalised HIV epidemic and among populations with high-risk behaviours, STI control can be cost-saving. 1 The World Health Organization (WHO) estimated that there are more than 340 million new cases of STIs globally among adults aged 15-49 years, 7 with 50 million annually in the Americas. 8 With this renewed emphasis on the importance of STIs control in the era of HIV, prompt diagnosis and treatment for STIs are crucial.
More than 75% of the STI burden is in the developing world, 7 where laboratory diagnoses of STIs are not always available or are costly. Recognising this challenge, the WHO developed guidelines for STI diagnosis and treatment in resource-constrained settings using syndromic management. 9 With the syndromic management approach, easily recognised signs and consistent groups of symptoms are identified as syndromes, which are then assigned treatment regimens that will address the majority of, or the most serious, organisms responsible for producing the respective syndrome. 9 Syndromic management relies on individuals recognising STI signs and symptoms, seeking healthcare and reporting symptoms to healthcare professionals. Numerous studies have been conducted to assess the effectiveness of STI syndromic management; [10] [11] [12] [13] [14] [15] however, data outside a healthcare setting have shown conflicting results. In a HIV voluntary testing and counselling setting, syndromic management can lead to many missed diagnoses and 3.2% overtreatment rates, while in a pharmacy setting the majority of symptomatic individuals were seropositive for an STI. 16, 17 Additionally, efficacy of these guidelines can vary by gender and disease type [10] [11] [12] [13] [14] [15] as some STIs can be asymptomatic, 18, 19 in which case syndromic management would have limited application and can lead to missed diagnoses.
The HIV prevalence in the general population in El Salvador is less than 1%. However, recent data have shown a high rate of STIs and HIV among high-risk populations in El Salvador. [20] [21] [22] Among men who have sex with men (MSM) in San Salvador, HIV prevalence was 14.5%, Herpes simplex virus-2 (HSV-2) was 49.8%, syphilis was 14.1% and other STIs were 11.1%. 20 Among people living with HIV/AIDS (PLWHA) in San Salvador, STI prevalence was 18.6%. 21, 23 According to a study among high-risk populations conducted in five Central American countries, MSM and female sex workers (FSWs) in El Salvador had the highest rates of HIV (15.3% and 3.2%, respectively), syphilis (15% in FSWs), gonorrhoea (10.7% in FSWs), chlamydia (23.3% in FSWs) and HSV-2 (56.5% and 95.7%, respectively) seroprevalence compared with other countries (other prevalence data not specifically stated). 24 Given the high prevalence of STIs in these populations, there is an urgent need to accurately identify and promptly treat STIs in El Salvador.
The objectives of this analysis were to determine if self-reported STI symptoms were an accurate measure for STI positivity by comparing them to laboratory diagnoses for three high-risk populations: FSWs, MSM and PLWHA; and if PLWHA participants differentially reported STIs compared to MSM and FSWs.
Methods
From March to September 2008, the El Salvador Ministry of Health conducted an integrated behavioural and biologic survey among MSM, FSW and PLWHA in San Salvador, Santa Ana, San Miguel and Sonsonate using methods described in detail elsewhere. 20, 22, 23 PLWHA were recruited from eight public hospitals from three cities that treat approximately 80% of all individuals with HIV infection in El Salvador. Participants were identified and sampled consecutively through HIV care and treatment programmes, HIV well-being programmes and HIV support groups. MSM and FSWs were recruited from March to September 2008 using respondent-driven sampling (RDS) 25, 26 in San Salvador, San Miguel and Sonsonate. Study sites were chosen based on high HIV care reporting, estimated STI prevalence rates and convenience and accessibility to the target populations. The protocol was approved by the US Centers for Disease Control and Prevention (CDC) and the Ethics Committee of Clinical Research of the National Hospital Rosales in El Salvador.
After written informed consent was obtained, participants completed both an audio computer-assisted survey instrument (ACASI) and face-to-face interview addressing demographic background, sexual behaviours, STI history and service utilisation. The face-toface interview was conducted by trained study staff. STI symptoms questions included asking whether the participant experienced any of the following symptoms in the last 12 months: vaginal or penile discharge, dysuria, genital or anal ulcers or wounds, genital itching, bad odour and genital or anal warts. If a participant was not familiar with these terms, the study staff defined these symptoms for participants. Women were also asked if they had any lower abdominal pain in the last 12 months. Following the interview, individuals were provided STI counselling and biological specimens (blood, urine, vaginal swabs for women and anal swabs for men) were collected by a trained laboratory technician. Individuals could refuse to participate in any component of the study. Syphilis testing was conducted using the rapid plasma reagin (RPR) test (Macro-Vue RPR; Becton, Dickinson and Company, USA) and confirmed by the Treponema pallidum particle agglutination (TPPA) test (Fujirebio Diagnostics, USA). Syphilis positivity was defined as serum-positive results for both RPR (at 1:8 or higher) and TPPA tests. HSV-2 testing was conducted serologically using HerpeSelect Õ (Herpes-Select; Focus Diagnostics, USA). HSV-2 seropositive was defined as having an index value of >1.1. Urine samples, vaginal swabs for women and anal swabs for men were tested using a multiplex real time polymerase chain reaction (PCR; Applied Biosystems GeneAmp; Life Technologies, USA) for Neisseria gonorrhoeae (GC), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV). For diagnosing bacterial vaginosis (BV) a Gram stain test was performed. After pre-test counselling, HIV testing for MSM and FSWs was performed at the study site using two rapid HIV tests (Determine Õ HIV-1/2; Abbott, USA and OraQuick Õ Advance Rapid HIV-1 Antibody Test; Orasure Technologies, USA). HIV results and posttest counselling were provided after 30 min. Serology tests were conducted at the Central Laboratory in El Salvador, and PCR and Gram stain tests were conducted at Gorgas Memorial Laboratory in Panama. PCR quality control was provided by the CDC Laboratory in Atlanta, USA. HIV-positive samples were sent to the National Reference Laboratory for confirmatory enzyme-linked immunosorbent assay (ELISA) testing. Participants were provided with a voucher with their study identification number to access their results at the study site after two weeks. If any test was positive, the participant was offered free treatment for diagnosed STIs and given a voucher for free partner STI testing and partner treatment as needed. If a participant reported STI symptoms, treatment was provided based on El Salvador's syndromic management guidelines. HIV-positive individuals were referred to the closest HIV clinic and encouraged to refer their partners for HIV testing at the nearest HIV testing centre.
Data entry and analysis
Data from the different sites for MSM and FSW recruitment were combined for data analysis. Results for GC and CT from urine and vaginal swabs or anal swabs were also combined. Face-to-face interview data were double data-entered and SPSS (version 12.0, Chicago, SPSS Inc.) was used for data management and recoding. Data analyses were conducted in SPSS and SAS version 9.2 (Cary, NC: SAS Institute, Inc). Among female participants, sensitivity, specificity and positive predictive values (PPVs) of self-reported vaginal discharge symptoms (discharge, pain/odour, lower back pain, itching) and laboratory-confirmed diagnoses of (1) GC or CT; (2) BV, TV or MG and (3) GC, CT, BV, TV or MG were calculated. Among male participants, sensitivity, specificity and PPVs of self-reported penile discharge symptoms (discharge, pain/odour, lower back pain, itching) and laboratory-confirmed diagnoses of (1) GC or CT; (2) TV or MG and (3) GC, CT, TV or MG were calculated. For both men and women, the same measures of sensitivity, specificity and PPV were calculated for self-reported genital ulcer symptoms and laboratory-confirmed diagnoses of syphilis or HSV-2 infections. This analysis was conducted at the specimen level for all study sites combined and therefore not adjusted for sampling design. 
Results

Demographic and laboratory-confirmed diagnoses
Self-reported symptoms
Among MSM, 86.1% did not report any penile inflammatory symptoms and 91.6% did not report any ulcerative symptoms in the last 12 months. Of the FSWs, 75.1% and 3.3% reported vaginal inflammatory and ulcerative symptoms, respectively. Of the male PLWHA, over 82% did not report any penile inflammatory or ulcerative symptoms. Among female PLWHA, 52.7% and 18.0% reported vaginal inflammatory and ulcerative symptoms, respectively ( Table 1) .
Performance of self-reported symptoms and laboratory results
Results for the sensitivity, specificity and PPV of selfreported symptoms compared with laboratory-diagnosed STI among FSWs and female PLWHA are presented in Table 2 . Among FSWs, sensitivity was between 74% and 75%, specificity ranged from 22% to 25% and PPV ranged from 13% to 79% for any self-reported vaginal inflammatory symptoms compared with laboratory-diagnosed STI. The sensitivity, specificity and PPV of genital ulcerative symptoms among FSWs compared with laboratory-diagnosed syphilis or HSV-2 infections were 3%, 96% and 80%, respectively. Among female PLWHA, sensitivity ranged from 25% to 52%, specificity was 47% and PPV from 1% to 52% for any self-reported vaginal inflammatory symptoms compared with laboratory-diagnosed STI. Sensitivity, specificity and PPV of genital ulcer symptoms among female PLWHA for laboratory-diagnosed syphilis or HSV-2 diagnoses were 19%, 88% and 92%, respectively. For inflammatory infections, FSWs had a higher sensitivity and PPV when compared to female PLWHA. For ulcerative infections, female PLWHA had a higher sensitivity than FSWs. Table 3 presents the results for the sensitivity, specificity and PPV of self-reported symptoms compared with laboratory-confirmed STI diagnosis among MSM and male PLWHA. Among MSM, sensitivity ranged from 12% to 17%, specificity was 86% and PPV ranged from 3% to 14% for any self-reported penile inflammatory symptoms compared with laboratory-diagnosed STI. The sensitivity, specificity and PPV of genital ulcerative symptoms compared with laboratory-confirmed syphilis or HSV-2 infections were 11%, 94% and 63%, respectively. Among male PLWHA, there were no laboratory-confirmed diagnoses of GC or CT. The sensitivity for TV or MG among male PLWHA was 28%, the specificity 84% and the PPV 15%. The sensitivity, specificity and PPV of genital ulcerative symptoms compared with laboratory-confirmed syphilis or HSV-2 infections were 19%, 90% and 89%, respectively. When comparing ulcerative symptoms, male PLWHA had a higher sensitivity and PPV than MSM.
Discussion
The high prevalence of laboratory-diagnosed STIs in these high-risk populations is concerning, especially among individuals infected with HIV, given the association between STIs and HIV transmission. 27 Though high rates of STI positivity were observed in these populations, the majority of men and a high percentage of women living with HIV were asymptomatic. These findings are consistent with previous studies 11, 19, 28 and suggest that self-reported symptoms in the last 12 months may not be reliable for detecting STIs. Outreach programmes for high-risk populations should thus consider an integrated approach of better recognition of STI signs and symptoms recognition, mobile-team outreach, presumptive treatment, condom promotion, routine or periodic STI screening and risk factors associated with STIs including partner STI status. [29] [30] [31] Similar to previous results, 14, 15, 19, 32, 33 the sensitivity, specificity and PPV analyses showed that STI screening, referral and treatment based solely on self-recognised and reported symptoms may not be an effective strategy for the high-risk populations in this study. Among female PLWHA, syndromic screening would have missed the majority of the GC or CT infections and about half of BV, TV or MG cases. Among all men, almost 80% of genital inflammatory infections would have been missed. These results were similar to those seen among high-risk men in previous studies. 19, 34 Though self-report of genital ulcerative infections had a high specificity, the majority of ulcerative cases in this study population would be missed if STI screening and referral was dependent on self-recognising and reporting of STI symptoms in the last 12 months. The addition of a physical examination, including a speculum examination for women and anoscopy for men, would likely improve these measures. 14 Sensitivity, specificity and PPV results for selfreported genital inflammatory infections were different when comparing men and women. This may be attributable to more men reporting no STI symptoms. These data suggest that routine screening may be useful even in the absence of self-reported symptoms in high-risk populations. [29] [30] [31] In contrast, sensitivity of self-recognition and report of genital inflammatory infections were higher among FSWs. The discrepancy seen in FSWs may be influenced by current programmes for FSWs in El Salvador that encourage FSWs to receive free HIV screening through the use of mobile units. 35 In 2007, the Ministry of Health published guidelines for physicians who work with FSWs regarding STI symptom recognition, risk factors, management and STI education for FSWs. 36 These interventions may be increasing STI awareness and symptom recognition by FSWs and may account for the increased sensitivity, specificity and PPV seen in this study within this population.
Our study had a number of limitations. The study was designed to assess behavioural risk factors. Further research should evaluate if similar results are found in a clinical setting. Questions regarding STI symptoms were included in the face-to-face questionnaire; thus, the data have been subject to underreporting due to social desirability bias. Respondents were asked about occurrence of symptoms over the 12 months prior to the study; however, STIs can remain asymptomatic in individuals, especially for anorectal STIs, for longer than 12 months. Therefore, both recall bias and potentially asymptomatic STIs, could lead to an underreporting of STI symptoms. In addition, not all participants in the survey responded to STI questions and agreed to STI testing. Therefore, our findings may not be generalisable to the population as a whole. Finally, the study is cross-sectional by design, and although the questionnaire asked about symptoms over the past 12 months, laboratory tests identified current infections and there were no data on whether participants sought treatment for the symptoms they reported. This would likely underestimate specificity and PPV; however, to what degree our findings may be affected is unknown.
To date, this is the first study to validate selfreported STI symptoms among FSWs, MSM and PLWHA in Central America. Our findings suggest that relying on self-reported STI symptoms may be a poor indicator of infection among high-risk groups in El Salvador as many infections are asymptomatic and can lead to missed diagnoses. In order to minimize missed diagnoses, especially in the setting of minimal STI laboratory capability and to reach high-risk populations, El Salvador should consider using creative methods including conducting risk assessment, STI symptom screening and physical examinations at research study sites. Additionally, encouraging referrals to clinics at study sites may aid in early identification and treatment of STIs. 37 The high prevalence of STI positivity noted in this study, their associated morbidity and the high cost of treating sequelae of STIs, 38 may justify the potential of overtreatment of patients using syndromic management. Further, because there is an increased risk of HIV transmission with STIs and that there is minimal STI laboratory testing capability in El Salvador, syndromic management may be an acceptable and the only alternative for high-risk populations in low-resource settings especially for symptomatic individuals. 39 Nevertheless, the evolution of resistant GC reported in North America and recently in South America and the Caribbean, can lead to the development of resistant strains in El Salvador as well. 40, 41 If possible, El Salvador should consider increasing their laboratory diagnostic capabilities to facilitate prompt STI diagnosis, appropriate treatment and to minimize development of resistant strains of STIs due to the potential for misdiagnosis with syndromic management. With limited laboratory resources, to increase referrals to STI clinics and prompt diagnosis, El Salvador should consider increasing efforts to provide more education regarding STI, improving symptom recognition and risk factors for STIs, and perhaps routine or periodic screening of high-risk individuals.
